2025 annual financial data
Supernus Pharmaceuticals 2025 Operating margin
Supernus Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -5.13%.
Operating income was -36,864,000 USD and net income was -38,550,000 USD.
Operating cash flow was 47,331,000 USD.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 718,952,000 USD
- Operating income
- -36,864,000 USD
- Net income
- -38,550,000 USD
- Operating cash flow
- 47,331,000 USD